KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Common Equity (2016 - 2025)

Edwards Lifesciences has reported Common Equity over the past 17 years, most recently at $10.3 billion for Q4 2025.

  • Quarterly results put Common Equity at $10.3 billion for Q4 2025, up 3.39% from a year ago — trailing twelve months through Dec 2025 was $10.3 billion (up 3.39% YoY), and the annual figure for FY2025 was $10.3 billion, up 3.39%.
  • Common Equity for Q4 2025 was $10.3 billion at Edwards Lifesciences, up from $10.2 billion in the prior quarter.
  • Over the last five years, Common Equity for EW hit a ceiling of $10.6 billion in Q2 2025 and a floor of $4.7 billion in Q1 2021.
  • Median Common Equity over the past 5 years was $6.6 billion (2023), compared with a mean of $7.3 billion.
  • Biggest five-year swings in Common Equity: decreased 0.5% in 2022 and later surged 48.8% in 2024.
  • Edwards Lifesciences' Common Equity stood at $5.8 billion in 2021, then dropped by 0.5% to $5.8 billion in 2022, then grew by 15.72% to $6.7 billion in 2023, then surged by 48.8% to $10.0 billion in 2024, then increased by 3.39% to $10.3 billion in 2025.
  • The last three reported values for Common Equity were $10.3 billion (Q4 2025), $10.2 billion (Q3 2025), and $10.6 billion (Q2 2025) per Business Quant data.